Targeted immunomodulation: a primer for intensivists.

Authors:
Janssen M; Endeman H; Bos LDJ.

Journal:
Intensive Care Med

Publication Year: 2023

DOI:
10.1007/s00134-023-07009-8

PMCID:
PMC9982766

PMID:
36867231

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Intensive Care Med

Abbreviation: Intensive Care Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Critical Care

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS-AKI trial.
Meersch M; Weiss R; Strauß C and 11 more (2024) - Transparency Score: 4/6
Clinical practice and effect of carbon dioxide on outcomes in mechanically ventilated acute brain-i…
Robba C; Battaglini D; Abbas A and 10 more (2024) - Transparency Score: 4/6
Equity in patient care in the intensive care unit.
Kotfis K; Olusanya S; Modra L. (2024) - Transparency Score: 2/6
Long-term outcomes with haloperidol versus placebo in acutely admitted adult ICU patients with deli…
Mortensen CB; Andersen-Ranberg NC; Poulsen LM and 23 more (2024) - Transparency Score: 3/6
Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute k…
Pickkers P; Angus DC; Bass K and 27 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflict of interestLB is supported by research funds from Innovative Health Initiative, ZonMW, Longfonds, Santhera and Amsterdam UMC. Conflict of interest LB is supported by research funds from Innovative Health Initiative, ZonMW, Longfonds, Santhera and Amsterdam UMC."

Evidence found in paper:

"Funding This research was funded by ZonMW, Grant no. [COVID-19 urgency grant: Immunomodulation]."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025